Skip to main content
Top
Gepubliceerd in: Tijdschrift voor Gerontologie en Geriatrie 1/2009

01-02-2009 | Klinische les

Cognitieve stoornissen en parkinsonisme bij gebruik van valproïnezuur

Auteurs: L. Schreur, C. W. Middeljans-Tijssen, G. J. D. Hengstman, M. G. M. Olde Rikkert

Gepubliceerd in: Tijdschrift voor Gerontologie en Geriatrie | Uitgave 1/2009

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Extract

Cognitieve stoornissen en parkinsonisme zijn frequent voorkomende aandoeningen bij oudere patiënten met een uitgebreide, veelal multifactoriële, differentiaal diagnose. De stoornissen leiden tot sterke beperkingen in het dagelijks functioneren en hebben een sterk negatieve invloed op de kwaliteit van leven. Meestal betreft het niet-reversibele aandoeningen, echter reversibele oorzaken dienen gezien het belang van de stoornissen niet over het hoofd gezien te worden. Eén van de meest voorkomende reversibele oorzaken is medicatie. Om deze reden willen wij onderstaande patiënten onder uw aandacht brengen, die beide grotendeels reversibele cognitieve stoornissen en parkinsonisme-achtige verschijnselen ontwikkelden ten gevolge van valproïnezuur. …
Literatuur
1.
go back to reference de la Court, Breteler MM, Meinardi H, Hauser WA, Hofman A. Prevalence of epilepsy in the elderly: the Rotterdam Study. Epilepsia 1996 Feb;37(2):141-7. de la Court, Breteler MM, Meinardi H, Hauser WA, Hofman A. Prevalence of epilepsy in the elderly: the Rotterdam Study. Epilepsia 1996 Feb;37(2):141-7.
2.
go back to reference Brodie MJ, Kwan P. Epilepsy in elderly people. BMJ 2005 Dec 3;331(7528):1317-22. Brodie MJ, Kwan P. Epilepsy in elderly people. BMJ 2005 Dec 3;331(7528):1317-22.
3.
go back to reference Hauser WA, Annegers JF. Risk factors for epilepsy. Epilepsy Res Suppl 1991;4:45-52. Hauser WA, Annegers JF. Risk factors for epilepsy. Epilepsy Res Suppl 1991;4:45-52.
4.
go back to reference Loiseau J, Loiseau P, Duche B, Guyot M, Dartigues JF, Aublet B. A survey of epileptic disorders in southwest France: seizures in elderly patients. Ann Neurol 1990 Mar;27(3):232-7. Loiseau J, Loiseau P, Duche B, Guyot M, Dartigues JF, Aublet B. A survey of epileptic disorders in southwest France: seizures in elderly patients. Ann Neurol 1990 Mar;27(3):232-7.
5.
go back to reference Mendez M, Lim G. Seizures in elderly patients with dementia: epidemiology and management. Drugs Aging 2003;20(11):791-803. Mendez M, Lim G. Seizures in elderly patients with dementia: epidemiology and management. Drugs Aging 2003;20(11):791-803.
6.
go back to reference Stephen LJ, Brodie MJ. Epilepsy in elderly people. Lancet 2000 Apr 22;355(9213):1441-6. Stephen LJ, Brodie MJ. Epilepsy in elderly people. Lancet 2000 Apr 22;355(9213):1441-6.
7.
go back to reference Roberts MA, Godfrey JW, Caird FI. Epileptic seizures in the elderly: I. Aetiology and type of seizure. Age Ageing 1982 Feb;11(1):24-8. Roberts MA, Godfrey JW, Caird FI. Epileptic seizures in the elderly: I. Aetiology and type of seizure. Age Ageing 1982 Feb;11(1):24-8.
8.
go back to reference Franson KL, Hay DP, Neppe V, Dahdal WY, Mirza WU, Grossberg GT, et al. Drug-induced seizures in the elderly. Causative agents and optimal management. Drugs Aging 1995 Jul;7(1):38-48. Franson KL, Hay DP, Neppe V, Dahdal WY, Mirza WU, Grossberg GT, et al. Drug-induced seizures in the elderly. Causative agents and optimal management. Drugs Aging 1995 Jul;7(1):38-48.
9.
go back to reference Hiyoshi T, Yagi K. Epilepsy in the elderly. Epilepsia 2000;41 Suppl 9:31-5. Hiyoshi T, Yagi K. Epilepsy in the elderly. Epilepsia 2000;41 Suppl 9:31-5.
10.
go back to reference Perucca E, Aldenkamp A, Tallis R, Kramer G. Role of valproate across the ages. Treatment of epilepsy in the elderly. Acta Neurol Scand Suppl 2006;184:28-37. Perucca E, Aldenkamp A, Tallis R, Kramer G. Role of valproate across the ages. Treatment of epilepsy in the elderly. Acta Neurol Scand Suppl 2006;184:28-37.
11.
go back to reference Hart YM, Sander JW, Johnson AL, Shorvon SD. National General Practice Study of Epilepsy: recurrence after a first seizure. Lancet 1990 Nov 24;336(8726):1271-4. Hart YM, Sander JW, Johnson AL, Shorvon SD. National General Practice Study of Epilepsy: recurrence after a first seizure. Lancet 1990 Nov 24;336(8726):1271-4.
12.
go back to reference Meinardi MC, van den Berg GB, Groenhuijzen A, Maas HAAM, Wolfhagen FHJ. Ned Tijdschr Geneeskd. 2008;152:278-82. Meinardi MC, van den Berg GB, Groenhuijzen A, Maas HAAM, Wolfhagen FHJ. Ned Tijdschr Geneeskd. 2008;152:278-82.
13.
go back to reference Hommet C, Mondon K, de TB, Constans T. Reversible cognitive and neurological symptoms during valproic acid therapy. J Am Geriatr Soc 2007 Apr;55(4):628. Hommet C, Mondon K, de TB, Constans T. Reversible cognitive and neurological symptoms during valproic acid therapy. J Am Geriatr Soc 2007 Apr;55(4):628.
14.
go back to reference Masmoudi K, Gras-Champel V, Bonnet I, Pannier M, Masson H, Rosa A, et al. [Dementia and extrapyramidal problems caused by long-term valproic acid]. Therapie 2000 Sep;55(5):629-34. Masmoudi K, Gras-Champel V, Bonnet I, Pannier M, Masson H, Rosa A, et al. [Dementia and extrapyramidal problems caused by long-term valproic acid]. Therapie 2000 Sep;55(5):629-34.
15.
go back to reference Masmoudi K, Gras-Champel V, Masson H, Andrejak M. Parkinsonism and/or cognitive impairment with valproic acid therapy: a report of ten cases. Pharmacopsychiatry 2006 Jan;39(1):9-12. Masmoudi K, Gras-Champel V, Masson H, Andrejak M. Parkinsonism and/or cognitive impairment with valproic acid therapy: a report of ten cases. Pharmacopsychiatry 2006 Jan;39(1):9-12.
16.
go back to reference Ristic AJ, Vojvodic N, Jankovic S, Sindelic A, Sokic D. The frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy. Epilepsia 2006 Dec;47(12):2183-5. Ristic AJ, Vojvodic N, Jankovic S, Sindelic A, Sokic D. The frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy. Epilepsia 2006 Dec;47(12):2183-5.
17.
go back to reference Easterford K, Clough P, Kellett M, Fallon K, Duncan S. Reversible parkinsonism with normal beta-CIT-SPECT in patients exposed to sodium valproate. Neurology 2004 Apr 27;62(8):1435-7. Easterford K, Clough P, Kellett M, Fallon K, Duncan S. Reversible parkinsonism with normal beta-CIT-SPECT in patients exposed to sodium valproate. Neurology 2004 Apr 27;62(8):1435-7.
18.
go back to reference Zadikoff C, Munhoz RP, Asante AN, Politzer N, Wennberg R, Carlen P, et al. Movement disorders in patients taking anticonvulsants. J Neurol Neurosurg Psychiatry 2007 Feb;78(2):147-51. Zadikoff C, Munhoz RP, Asante AN, Politzer N, Wennberg R, Carlen P, et al. Movement disorders in patients taking anticonvulsants. J Neurol Neurosurg Psychiatry 2007 Feb;78(2):147-51.
19.
go back to reference Armon C, Shin C, Miller P, Carwile S, Brown E, Edinger JD, et al. Reversible parkinsonism and cognitive impairment with chronic valproate use. Neurology 1996 Sep;47(3):626-35. Armon C, Shin C, Miller P, Carwile S, Brown E, Edinger JD, et al. Reversible parkinsonism and cognitive impairment with chronic valproate use. Neurology 1996 Sep;47(3):626-35.
20.
go back to reference Ikebe S, Tanaka M, Ohno K, Sato W, Hattori K, Kondo T, et al. Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence. Biochem Biophys Res Commun 1990 Aug 16;170(3):1044-8. Ikebe S, Tanaka M, Ohno K, Sato W, Hattori K, Kondo T, et al. Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence. Biochem Biophys Res Commun 1990 Aug 16;170(3):1044-8.
21.
go back to reference Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, et al. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun 1989 Sep 29;163(3):1450-5. Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, et al. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun 1989 Sep 29;163(3):1450-5.
22.
go back to reference Parker WD, Jr., Boyson SJ, Parks JK. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann Neurol 1989 Dec;26(6):719-23. Parker WD, Jr., Boyson SJ, Parks JK. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann Neurol 1989 Dec;26(6):719-23.
23.
go back to reference Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 1990 Mar;54(3):823-7. Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 1990 Mar;54(3):823-7.
24.
go back to reference Schapira AH, Mann VM, Cooper JM, Dexter D, Daniel SE, Jenner P, et al. Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J Neurochem 1990 Dec;55(6):2142-5. Schapira AH, Mann VM, Cooper JM, Dexter D, Daniel SE, Jenner P, et al. Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J Neurochem 1990 Dec;55(6):2142-5.
25.
go back to reference Nicklas WJ, Vyas I, Heikkila RE. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci 1985 Jul 1;36(26):2503-8. Nicklas WJ, Vyas I, Heikkila RE. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci 1985 Jul 1;36(26):2503-8.
Metagegevens
Titel
Cognitieve stoornissen en parkinsonisme bij gebruik van valproïnezuur
Auteurs
L. Schreur
C. W. Middeljans-Tijssen
G. J. D. Hengstman
M. G. M. Olde Rikkert
Publicatiedatum
01-02-2009
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Tijdschrift voor Gerontologie en Geriatrie / Uitgave 1/2009
Print ISSN: 0167-9228
Elektronisch ISSN: 1875-6832
DOI
https://doi.org/10.1007/BF03088474

Andere artikelen Uitgave 1/2009

Tijdschrift voor Gerontologie en Geriatrie 1/2009 Naar de uitgave

Signalementen

Signalementen

Proefschriften in discussie

Proefschriften in discussie

Congresagenda

Congersagenda